Literature DB >> 2094580

A malaria sporozoite surface antigen distinct from the circumsporozoite protein.

R C Hedstrom1, J R Campbell, M L Leef, Y Charoenvit, M Carter, M Sedegah, R L Beaudoin, S L Hoffman.   

Abstract

Monoclonal antibody NYS4 recognizes a single 140 kDa antigen on the surface of Plasmodium yoelii sporozoites, an antigen which is distinct from the extensively characterized circumsporozoite (CS) protein. To more thoroughly characterize this additional surface component, a genomic expression library was screened with NYS4 and an immunoreactive clone (M4) was obtained which expressed part of the antigen gene. The deduced amino acid sequence of the M4 peptide included two unique repetitive sequences of amino acids and a conserved sequence motif which is found in several proteins including the CS protein (region II). The cloned DNA hybridized to a PCR (polymerase chain reaction) amplified sporozoite mRNA demonstrating the sporozoite-stage expression of this gene. A synthetic peptide of one of the repeats, (Asn-Pro-Asn-Glu-Pro-Ser), was recognized by NYS4 and mice immunized with (Asn-Pro-Asn-Glu-Pro-Ser)3 conjugated to KLH (keyhole limpet haemocyanin) produced high levels of antibodies that reacted with the surface of sporozoites and specifically to the 140 kDa antigen. Thus, at least two different proteins are on the surface of the P. yoelii sporozoite indicating that the immunoreactive exterior of the infective stage of malaria parasites is more antigenically complex than previously thought.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2094580      PMCID: PMC2393018     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  20 in total

1.  Human T-cell recognition of the circumsporozoite protein of Plasmodium falciparum: immunodominant T-cell domains map to the polymorphic regions of the molecule.

Authors:  M F Good; D Pombo; I A Quakyi; E M Riley; R A Houghten; A Menon; D W Alling; J A Berzofsky; L H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

2.  Unidirectional digestion with exonuclease III in DNA sequence analysis.

Authors:  S Henikoff
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  Cloning of Plasmodium yoelii genes expressing three different sporozoite-specific antigens.

Authors:  A Wortman; P Rogers; Y Charoenvit; A McDermott; M Leef; M Sedegah; R L Beaudoin
Journal:  Microb Pathog       Date:  1989-03       Impact factor: 3.738

4.  Properdin, the terminal complement components, thrombospondin and the circumsporozoite protein of malaria parasites contain similar sequence motifs.

Authors:  D Goundis; K B Reid
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

5.  A highly conserved amino-acid sequence in thrombospondin, properdin and in proteins from sporozoites and blood stages of a human malaria parasite.

Authors:  K J Robson; J R Hall; M W Jennings; T J Harris; K Marsh; C I Newbold; V E Tate; D J Weatherall
Journal:  Nature       Date:  1988-09-01       Impact factor: 49.962

6.  Antibody-induced ultrastructural changes of malarial sporozoites.

Authors:  A H Cochrane; M Aikawa; M Jeng; R S Nussenzweig
Journal:  J Immunol       Date:  1976-03       Impact factor: 5.422

7.  Immune response gene regulation of immunity to Plasmodium berghei sporozoites and circumsporozoite protein vaccines. Overcoming genetic restriction with whole organism and subunit vaccines.

Authors:  S L Hoffman; J A Berzofsky; D Isenbarger; E Zeltser; W R Majarian; M Gross; W R Ballou
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

8.  Antistasin, an inhibitor of coagulation and metastasis, binds to sulfatide (Gal(3-SO4) beta 1-1Cer) and has a sequence homology with other proteins that bind sulfated glycoconjugates.

Authors:  G D Holt; H C Krivan; G J Gasic; V Ginsburg
Journal:  J Biol Chem       Date:  1989-07-25       Impact factor: 5.157

9.  Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes.

Authors:  S L Hoffman; D Isenbarger; G W Long; M Sedegah; A Szarfman; L Waters; M R Hollingdale; P H van der Meide; D S Finbloom; W R Ballou
Journal:  Science       Date:  1989-06-02       Impact factor: 47.728

10.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease.

Authors:  J M Chirgwin; A E Przybyla; R J MacDonald; W J Rutter
Journal:  Biochemistry       Date:  1979-11-27       Impact factor: 3.162

View more
  19 in total

Review 1.  The development of a multivalent DNA vaccine for malaria.

Authors:  R C Hedstrom; D L Doolan; R Wang; M J Gardner; A Kumar; M Sedegah; R A Gramzinski; J B Sacci; Y Charoenvit; W R Weiss; M Margalith; J A Norman; P Hobart; S L Hoffman
Journal:  Springer Semin Immunopathol       Date:  1997

Review 2.  Class I HLA-restricted cytotoxic T lymphocyte responses against malaria--elucidation on the basis of HLA peptide binding motifs.

Authors:  D L Doolan; B Wizel; S L Hoffman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

Review 3.  Cell invasion by the vertebrate stages of Plasmodium.

Authors:  P Sinnis; B K Sim
Journal:  Trends Microbiol       Date:  1997-02       Impact factor: 17.079

4.  CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.

Authors:  Y Charoenvit; V F Majam; G Corradin; J B Sacci; R Wang; D L Doolan; T R Jones; E Abot; M E Patarroyo; F Guzman; S L Hoffman
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes.

Authors:  Y Charoenvit; V Fallarme; W O Rogers; J B Sacci; M Kaur; J C Aguiar; L F Yuan; G Corradin; E Andersen; B Wizel; R A Houghten; A Oloo; P De la Vega; S L Hoffman
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG.

Authors:  S M Gantt; P Clavijo; X Bai; J D Esko; P Sinnis
Journal:  J Biol Chem       Date:  1997-08-01       Impact factor: 5.157

7.  Serum antibody immunoglobulin G of mice convalescent from Plasmodium yoelii infection inhibits growth of Plasmodium falciparum in vitro: blood stage antigens of P. falciparum involved in interspecies cross-reactive inhibition of parasite growth.

Authors:  P Ray; N Sahoo; B Singh; F A Kironde
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.

Authors:  S Chatterjee; M Wery; P Sharma; V S Chauhan
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

9.  Characterization of Plasmodium falciparum sporozoite surface protein 2.

Authors:  W O Rogers; A Malik; S Mellouk; K Nakamura; M D Rogers; A Szarfman; D M Gordon; A K Nussler; M Aikawa; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

10.  Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.

Authors:  M Sedegah; R Hedstrom; P Hobart; S L Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-10-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.